Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'purotoxin 1'

Search results for: 'purotoxin 1'

Items 31-40 of 82

Page
per page
  1. Tipifarnib (Zarnestra)
    A4227 Tipifarnib (Zarnestra)
    Summary: Farnesyltransferase inhibitor,potent and specific
      insoluble in H2O; ≥8.16 mg/mL
  2. Ketoconazole
    A4316 Ketoconazole
    Target: Cytochrome P450 (CYP450)
    Summary: Inhibitor of cyclosporine oxidase and testosterone 6 beta-hydroxylase
      ≥23.4 mg/mL
  3. Avasimibe
    A4318 Avasimibe
    Target: Acyl coenzyme A: cholesterol acyltransferases
    Summary: ACAT inhibitor,orally bioavailable
      ≥25.09 mg/mL
  4. Pralatrexate
    A4350 Pralatrexate
    Summary: Antifolate,a folate analog
      ≥23.85 mg/mL
  5. U-104
    A4358 U-104
    Target: Carbonic Anhydrases
    Summary: CAIX inhibitor
      insoluble in H2O; ≥11.5 mg/mL
  6. Rasagiline Mesylate
    A4366 Rasagiline Mesylate
    Summary: Irreversible MAO-B inhibitor
      ≥13.37 mg/mL
  7. NLG919
    A4373 NLG919
     1 Citation
    Summary: Potent IDO pathway inhibitor
      insoluble in H2O; insoluble in EtOH; ≥47.7 mg/mL
  8. FK866 (APO866)
    A4381 FK866 (APO866)
     1 Citation
    Target: Nampt
    Summary: NAMPT inhibitor, non-competitive, highly specific
      insoluble in H2O; ≥19.6 mg/mL
  9. NCT-501
    B6044 NCT-501
    Summary: Aldehyde Dehydrogenase 1A1 (ALDH1A1) inhibitor, Potent and Selective
      ≥20.85 mg/mL
  10. DL-α-Hydroxyglutaric acid disodium salt
    A3837 DL-α-Hydroxyglutaric acid disodium salt
    Summary: alpha hydroxy acid
      insoluble in DMSO; insoluble in EtOH; ≥69.4 mg/mL

Items 31-40 of 82

Page
per page
Shop By
Now Shopping by
  1. Category Metabolism Remove This Item
Clear All
Shopping Options
Category
  1. PPAR 6item
  2. 5-Lipoxygenase 3item
  3. Adenosine Deaminase 2item
  4. Aminopeptidase 1 item
  5. Carbonic Anhydrase 1 item
  6. Cholesterol absorption 1 item
  7. CPT1 1 item
  8. CYP3A/CYP450 3item
  9. Dehydrogenase 7item
  10. DHFR 2item
  11. DGAT 4item
  12. Dopamine β-hydroxylase 1 item
  13. FAAH 1 item
  14. Ferroptosis 3item
  15. Folate Analogue 1 item
  16. HMG-CoA Reductase 3item
  17. HSP 4item
  18. IDO 4item
  19. KRAS-PDEδ 1 item
  20. Lipid Metabolism 1 item
  21. MAO 1 item
  22. Neuronal Metabolism 1 item
  23. P450 5item
  24. PDE 4item
  25. Phospholipase 4item
  26. Procollagen C Proteinase 1 item
  27. SCD 1 item
  28. SGLT 1 item
  29. TPH 2item
  30. Transferase 8item
  31. aldehyde dehydrogenase 1 item
  32. Amino acid metabolism 1 item
  33. Galactosidase 1 item
  34. Lipase inhibitor 1 item
Specificity
  1. Selective 16item
Reversibility
  1. Irreversible 1 item
Target
  1. Acyl coenzyme A: cholesterol acyltransferases 1 item
  2. Phosphodiesterases (PDEs) 1 item
  3. Aminopeptidases 1 item
  4. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  5. Cytochrome P450 (CYP450) 1 item
  6. Ferroptosis 1 item
  7. HMG-CoA Reductases 1 item
  8. DGAT 2item
  9. Lactate Dehydrogenases (LDH) 1 item
  10. Nampt 1 item
  11. Carbonic Anhydrases 1 item
  12. Aldehyde Dehydrogenases 1 item
  13. Tryptophan hydroxylases (TPH) 1 item
  14. PPAR 1 item
  15. Ftase 1 item
  16. HMGCR 1 item
  17. Tph 1 item
  18. Cholesterol absorption 1 item
Reported Experiments
  1. Animal Experiments 25item
  2. Cell Experiments 21item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Breast Cancer 3item
  3. Cancer 6item
  4. Epilepsy 1 item
  5. Glioma 1 item
  6. Hypercholesterolemia 2item
  7. Leukemia 1 item
  8. Lung Cancer 1 item
  9. Lymphoma 1 item
  10. Melanoma 2item
  11. Neuroblastoma 1 item
  12. Pancreatic Cancer 1 item
  13. Prostate Cancer 2item
  14. Psoriasis 1 item